So with a predicted revenue for CY24 for Daybue being $370m-$420m and the first quarter predicted at $80m it would seem that these figures may indicate quarterly growth of 10-15% with $95m, $115m and $130m taking figures up to $420m
If we use the lower end of growth at 10% for year 2025 we would get
Q1 $100m
Q2 $140m
Q3 $155m
Q4 $170m
or totalling ~ $550m and the trigger of another $50m milestone payment
Also 2025 should see some revenue flow from Canada
Not bad year on year revenue where it would seem various milestone triggers will complement royalties for a few years to come
- Forums
- ASX - By Stock
- NEU
- Ann: 2023 Results webinar
NEU
neuren pharmaceuticals limited
Add to My Watchlist
10.1%
!
$13.81

Ann: 2023 Results webinar, page-46
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.81 |
Change
1.270(10.1%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.96 | $13.88 | $12.91 | $3.770M | 281.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 27 | $13.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.81 | 79 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 228 | 13.830 |
2 | 323 | 13.820 |
5 | 569 | 13.810 |
5 | 1336 | 13.800 |
3 | 552 | 13.790 |
Price($) | Vol. | No. |
---|---|---|
13.880 | 1801 | 3 |
13.890 | 244 | 2 |
13.900 | 6218 | 8 |
13.910 | 1133 | 3 |
13.920 | 591 | 3 |
Last trade - 10.25am 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online